The largest database of trusted experimental protocols

Ceretec

Manufactured by GE Healthcare
Sourced in United Kingdom

Ceretec is a diagnostic imaging agent used in conjunction with single-photon emission computed tomography (SPECT) imaging. It is designed to provide information about the brain's blood flow and function.

Automatically generated - may contain errors

7 protocols using ceretec

1

HMPAO and 99mTc-MAA Radiotracer Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HMPAO (Ceretec®) was purchased in kit form from GE Healthcare (Arlington Heights, IL), and technetium-labeled macroaggregated albumin (99mTc-MAA, particle sizes 20 – 40 μm) was purchased from Cardinal Health (Wauwatosa, WI). Antibodies to 3-nitrotyrosine (3-NT) (Abcam, # ab52309), and keratin 4-hydroxynonenal (4-HNE) (Abcam, # ab46545) were used with appropriate secondary antibodies (mouse 1:3000 for 3-NT and rabbit 1:3000) to measure expression of 3-nitrotyrosine (3-NT) and 4-hydroxynonenal (4-HNE) in lung tissue homogenate. Diethyl maleate (DEM) and other reagent grade chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
2

Multimodal Imaging for Clinical Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The decision to perform other imaging modalities (MRI, three-phase bone scintigraphy, infection scan with labeled leukocytes or antigranulocyte antibodies, and occasionally CT) (Table 3) was based on the judgment of clinical indications in each case. The three-phase bone scintigraphy (bone scan) was performed with 99mTc-HDP or DPD (mean dose 670 MBq). Infection scans were performed using either 99mTc-white blood cell scanning (HMPAO, Ceretec, GE Healthcare, Amersham Place, United Kingdom, mean dose 209 MBq) or 99mTc-antigranulocyte scintigraphy (LeukoScan®, Immunomedics GmbH, Darmstadt, Germany, mean dose 1000 MBq) technique. Based on the interpretation of the clinical reviewers, the results were recorded as true positive or false negative (Table 3).
+ Open protocol
+ Expand
3

Radiolabeled Tracers and Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
HMPAO (Ceretec®) was purchased from GE Healthcare (Arlington Heights, IL), and technetium-labeled macroaggregated albumin (99mTc-MAA, particle sizes 20 – 40 µm) was purchased from Cardinal Health (Wauwatosa, WI). Antibody to myeloperoxidase (MPO) (Abcam # Ab9535) was used with secondary antibody (Abcam #6829 HRP) to identify MPO positive cells. Diethyl maleate (DEM) and other reagent grade chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
4

SPECT Imaging with Technetium-99m

Check if the same lab product or an alternative is used in the 5 most similar protocols
Less than 24 hours prior to each SPECT scan a 99Mo generator was eluted. Approximately 1,85 GBq 99mTcO4 was added to the exametazime (d,1 hexamethylpropylene amine oxime (HMPAO); Ceretec®, GE Healthcare LTD, UK).
+ Open protocol
+ Expand
5

SPECT Imaging of Technetium-99m Tracers

Check if the same lab product or an alternative is used in the 5 most similar protocols
A SPECT scan was obtained by a nuclear medicine physician for every patient during follow-up. The procedure used was as follows. The patients received an injection of 740 MBq of [99mTc]ethyl cysteinate dimer (Neurolite; Lantheus Medical Imaging, North Billerica, MA, USA) (eight patients received 740 MBq of [99mTc]exametazime Ceretec; GE Healthcare, Little Chalfont, UK). The image acquisition began 15 minutes after injection with a dual-head gamma camera (Siemens Medical Imaging, Hoffman Estates, IL, USA) equipped with a fan beam collimator specially manufactured for the study of the brain. Patients were imaged while in the supine position. The heads of the gamma camera were 15 cm away from the center of rotation. The height of the table was 20 cm. Image acquisition included 32 tomographic projections of 50 seconds each. The acquisition matrix was 128 × 128 pixels with zoom set at 1.23. The acquisition window was focused on the energy of the 99mTc isotope photopeak (that is, 140 keV) with a window width of 15%.
+ Open protocol
+ Expand
6

Autologous WBC Labeling and SPECT/CT Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
The labelling of autologous WBCs with prepared 99mTc-HMPAO (Ceretec; GE Healthcare, Oslo, Norway) was based on previously published consensus papers and guidelines with adjustments to the local needs31 (link). WBC SPECT/CT was performed on a dedicated hybrid dual-head SPECT/CT scanner (Symbia Intevo, Siemens Medical Solutions, IL) using a low-energy high-resolution, parallel hole collimator 4 h after the intravenous injection of 740 MBq 99mTc-HMPAO-labeled WBCs. SPECT was acquired at 64 stops per detector (angle of 2.813°) at 25 s/stop. CT was performed without using a contrast agent with a 16-slice helical CT scanner, and the images were reconstructed into 0.75-mm slices (130 kV, 100 mA in the Auto-mA mode, and pitch 1.2). CT-based attenuation-corrected SPECT and quantitative SPECT were reconstructed on 256 × 256 matrices using Flash 3D-ordered subset expectation maximization and an ordered subset conjugate gradient maximization (xSPECT Quant, Siemens Medical Solutions, IL) algorithms (eight subsets and four iterations; Gaussian filter of 8.0), respectively. Finally, the SPECT and CT images were co-registered as fusion SPECT/CT images.
+ Open protocol
+ Expand
7

Cerebral Blood Flow Imaging in Pigs

Check if the same lab product or an alternative is used in the 5 most similar protocols
During 4 weeks, the pigs underwent four brain-imaging sessions each to investigate the brain metabolism following oral and/or duodenal stimulations with sucrose. The brain imaging modality used to investigate cerebral blood flow (CBF) was the SPECT of technetium-99m (99mTc, CIS Bio International, France) coupled with hexamethyl-propylene-amine-oxime (HMPAO, Ceretec, GE Healthcare, Velizy, France).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!